Shop today >> Free Shipping for orders $50 and up

All Blogs

CareSens N Feliz BT: our newest blood glucose meter approved by FDA

i-SENS USA is delighted to introduce CareSens N Feliz, which has passed the strict and rigorous evaluation and won the FDA approval on Oct 5, 2021. We are proud to add another FDA approved to our blood glucose meter portfolio even while the competition was especially dense due to covid related delays. CareSens N Feliz meter also...

CareSens N Feliz BT: our newest blood glucose meter approved by FDA

CareSens N Feliz is the meter to further meet needs of the users by offering display features with intuitive symbols to indicate Normal, High (hyperglycemia), or LOW (Hypoglycemia) for each test result. The range can be customized to fit the user’s health profile. The meter is compatible with original CareSens N strips.

Diabetes 101

Diabetes is a common, chronic metabolic condition in which the concentration of glucose in the blood becomes higher than normal (hyperglycemia).  While diabetes currently has no cure, it can be well-controlled under persistent and careful management. Close glucose monitoring and injection therapies, along with lifestyle changes, are among the top management strategies. On the other hand, unregulated...

What is PCOS and how is it related to Type 2 diabetes?

Polycystic ovary syndrome, also known as PCOS, is an endocrine-metabolic disorder that is reported to occur in about 5-12% of women* of reproductive age. It is characterized by multiple features, including accumulation of immature follicles developing in the ovary, hyperandrogenism (excessive level of androgen), irregular or missed menstruation, and obesity. PCOS is especially concerning for women as...

Find i-SENS USA at Total Store Expo 2021 Virtual

As the industry’s largest gathering, the NACDS (National Association of Chain Drug Stores) Total Store Expo has been providing interactive platforms that allow retailers to search, discover, and connect through strategic and tactical business meetings between existing and new trading partners.